Deutsche Bank Ag\ Biotechnology

Deutsche Bank Ag\

$248 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ADCT Adc Therapeutics Sa	$125M	$111,000 0.0% of portfolio	56,062	Q4 2024 Added 40.7%
INZY Inozyme Pharma, Inc.	$38.9M	$111,000 0.0% of portfolio	40,215	Q4 2024 Added 29.06%
ELEV Elevation Oncology, Inc.	$6.99M	$109,000 0.0% of portfolio	188,771	Q4 2024 Added 550.49%
NKTX Nkarta, Inc.	$73M	$107,000 0.0% of portfolio	43,157	Q4 2024 Added 26.15%
OVID Ovid Therapeutics Inc.	$31.7M	$97,000 0.0% of portfolio	105,177	Q2 2024 Added 338.58%
PROK Prokidney Corp Ord Shs Cl A(Cy	$59.1M	$97,000 0.0% of portfolio	57,791	Q3 2024 Added 57.44%
ITOS I Teos Therapeutics, Inc.	$245M	$96,000 0.0% of portfolio	12,531	Q4 2024 Reduced 53.5%
HRTX Heron Therapeutics, Inc.	$283M	$91,000 0.0% of portfolio	59,786	Q3 2024 Added 90.91%
BCYC Bicycle Therapeutics PLC	$269M	$89,000 0.0% of portfolio	6,417	Q4 2024 Reduced 20.48%
LCTX Lineage Cell Therapeutics, Inc.	$86.6M	$87,000 0.0% of portfolio	174,702	Q4 2024 Added 195.95%
QSI Quantum Si Inc	$174M	$87,000 0.0% of portfolio	32,560	Q2 2024 Reduced 20.51%
SAVA Cassava Sciences Inc	$114M	$86,000 0.0% of portfolio	36,571	Q4 2024 Added 42.68%
NKTR Nektar Therapeutics	$161M	$82,000 0.0% of portfolio	88,549	Q3 2024 New
CRBU Caribou Biosciences, Inc.	$63.3M	$78,000 0.0% of portfolio	49,576	Q3 2024 Added 65.37%
PGEN Precigen, Inc.	$377M	$75,000 0.0% of portfolio	67,302	Q3 2024 Added 63.49%
IGMS Igm Biosciences, Inc.	$34.5M	$68,000 0.0% of portfolio	11,227	Q4 2024 Added 0.21%
VTYX Ventyx Biosciences, Inc.	$74.6M	$66,000 0.0% of portfolio	30,328	Q3 2024 Added 71.1%
TCRX T Scan Therapeutics, Inc.	$31.6M	$63,000 0.0% of portfolio	21,078	Q4 2024 Added 2.13%
FHTX Foghorn Therapeutics Inc.	$169M	$58,000 0.0% of portfolio	12,310	Q3 2024 Added 57.02%
CHRS Coherus Bio Sciences, Inc.	$80.1M	$54,000 0.0% of portfolio	39,475	Q2 2024 Reduced 68.55%
LYEL Lyell Immunopharma, Inc.	$144M	$52,000 0.0% of portfolio	82,441	Q3 2024 Added 41.36%
CABA Cabaletta Bio, Inc.	$50.5M	$49,000 0.0% of portfolio	22,361	Q3 2024 Added 59.52%
BDTX Black Diamond Therapeutics, Inc.	$64.7M	$47,000 0.0% of portfolio	22,388	Q2 2024 New
MLTX Moon Lake Immunotherapeutics	$1.48B	$47,000 0.0% of portfolio	903	Q4 2024 Added 59.82%
PYXS Pyxis Oncology, Inc.	$42.5M	$46,000 0.0% of portfolio	30,300	Q4 2024 Reduced 87.29%
NAUT Nautilus Biotechnology, Inc.	$123M	$37,000 0.0% of portfolio	22,369	Q1 2024 Reduced 31.57%
ALLO Allogene Therapeutics, Inc.	$233M	$13,000 0.0% of portfolio	6,563	Q4 2024 Reduced 90.51%
ZLAB Zai Lab LTD	$3.44B	$8,000 0.0% of portfolio	332	Q4 2024 Reduced 65.95%
MGNX Macrogenics Inc	$128M	$4,000 0.0% of portfolio	1,309	Q4 2024 Reduced 97.02%
OCGN Ocugen, Inc.	$130M	$4,000 0.0% of portfolio	6,207	Q4 2024 Reduced 96.38%
VRCA Verrica Pharmaceuticals Inc.	$327M	$4,000 0.0% of portfolio	591	Q3 2024 Reduced 99.68%
XOMA Xoma Corp	$239M	$3,000 0.0% of portfolio	124	Q3 2024 Added 933.33%
AVTE Aerovate Therapeutics, Inc.	$61.6M	$1,000 0.0% of portfolio	720	Q4 2024 Added 4,135.29%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	43,377	Q4 2024 Added 50.76%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.